Stoke Therapeutics Inc.
(STOK)
undefined
undefined%
At close: undefined
12.06
0.08%
After-hours Dec 13, 2024, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Net Income | -104.70M | -101.07M | -85.81M | -52.24M | -32.33M | -12.52M | -5.56M |
| Depreciation & Amortization | 2.47M | 1.55M | 974.00K | 888.00K | 450.00K | 214.00K | 113.00K |
| Stock-Based Compensation | 25.26M | 22.85M | 16.45M | 5.77M | 1.92M | 240.00K | 26.00K |
| Other Working Capital | -2.82M | 42.90M | -2.85M | -2.88M | -2.00M | 1.09M | 31.00K |
| Other Non-Cash Items | 1.94M | 1.78M | 1.26M | 1.04M | 3.00K | 10.00K | 4.00K |
| Deferred Income Tax | - | - | 172.00K | 3.00K | - | - | - |
| Change in Working Capital | -6.03M | 43.02M | 46.00K | 2.33M | -1.10M | 1.09M | 31.00K |
| Operating Cash Flow | -81.07M | -31.87M | -66.91M | -42.22M | -31.05M | -10.96M | -5.38M |
| Capital Expenditures | -1.62M | -3.96M | -1.20M | -1.05M | -1.64M | -935.00K | -113.00K |
| Acquisitions | - | 45.34M | 75.23M | - | 1K | 10.00K | - |
| Purchase of Investments | - | -201.32M | -87.23M | - | - | - | - |
| Sales Maturities Of Investments | 107.56M | 159.40M | 12.00M | - | - | - | - |
| Other Investing Acitivies | - | -45.34M | -75.23M | - | 1K | 10.00K | - |
| Investing Cash Flow | 105.95M | -45.88M | -76.43M | -1.05M | -1.63M | -925.00K | -113.00K |
| Debt Repayment | - | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - |
| Other Financial Acitivies | 926.00K | 1.06M | 1.28M | 2.71M | -2.15M | 115.64M | 5.97M |
| Financial Cash Flow | 53.01M | 46.41M | 1.28M | 108.11M | 149.76M | 115.64M | 5.97M |
| Net Cash Flow | 77.89M | -31.34M | -142.05M | 64.84M | 117.07M | 103.75M | 477.00K |
| Free Cash Flow | -82.68M | -35.83M | -68.11M | -43.27M | -32.69M | -11.90M | -5.50M |